Ownership history in BVF INC/IL · 31 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in PROTAGONIST THERAPEUTICS INC (PTGX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,560,916 | -650,125 | -20.2% | 6.90% | $170.1M | $66.43 |
| 2025 Q2 | ADDED | 3,211,041 | +636,026 | +24.7% | 6.34% | $177.5M | $55.27 |
| 2025 Q1 | ADDED | 2,575,015 | +675,000 | +35.5% | 5.08% | $124.5M | $48.36 |
| 2024 Q4 | ADDED | 1,900,015 | +49,848 | +2.7% | 2.49% | $73.3M | $38.60 |
As of 2025 Q4 — sorted by position size